Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Exact Sciences (EXAS) PT Raised to $118 at Canaccord Genuity
-
Quest Diagnostics (DGX) PT Raised to $108 at Canaccord Genuity
-
Illumina (ILMN) PT Raised to $377 at Canaccord Genuity
-
Collins Foods Ltd. (CKF:AU) PT Raised to AUD8.10 at Canaccord Genuity
-
Ausdrill Ltd. (ASL:AU) PT Raised to AUD2.05 at Canaccord Genuity
-
Marston's (MARS:LN) (MARZF) PT Raised to GBp130 at Canaccord Genuity
-
Edgewater Wireless Closes First Tranche of Private Placement
-
Canaccord Genuity Downgrades MOD Resources (MOD:AU) (MDRSF) to Hold
-
Canaccord Genuity Downgrades Saracen Mineral Holdings Ltd. (SAR:AU) (SCEXF) to Sell
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $84 at Canaccord Genuity, Earlier
-
Canaccord Genuity Releases Company Update Research Report on CLS Holdings USA, Inc.
-
Canaccord Genuity Releases Company Update Research Report on CLS Holdings USA, Inc.
-
Goldmoney Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2019
-
TransGlobe Energy Corporation Announces PDMR Shareholding
-
Burford Capital (BUR:LN) (BRFRF) PT Raised to GBP1,240 at Canaccord Genuity
-
Palatin Technologies (PTN) Compares Favorably To Addyi - Canaccord
-
Canaccord Genuity Reiterates Buy Rating on CEVA Inc. (CEVA) After Upbeat European Investor Meetings - Canaccord
-
Canaccord Genuity Reiterates Buy Rating on AeroVironment (AVAV) Ahead of 4Q Report
-
Canaccord Genuity Downgrades Syrah Resources Ltd. (SYR:AU) to Hold
-
Alliance Trust PLC - Appointment of Corporate Broker
-
Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
HMS Holdings Corp. (HMSY) Sell-Off 'Overdone', Would Buy on This Pullback - Canaccord
-
IQE shares plunge as Huawei ban hammers tech suppliers
-
IQE Plc. (IQE:LN) (IQEPF) PT Lowered to GBp85 at Canaccord Genuity
-
Trading update
-
Everbridge (EVBG) PT Raised to $105 at Canaccord Genuity
-
Shopify (SHOP) PT Raised to $360 at Canaccord Genuity
-
Ero Copper Corp. (ERO:CN) (ERRPF) PT Raised to Cdn$24 at Canaccord Genuity
-
Champion Iron Ltd. (CIA:CN) (CHPRF) PT Raised to Cdn$4.50 at Canaccord Genuity
-
Atreca (BCEL) IPO Opens 17% Higher
-
Atreca, Inc. (BCEL) Prices 7.35M Share IPO at $17/Sh
-
Atreca Announces Pricing of Initial Public Offering
-
Atreca Announces Pricing of Initial Public Offering
-
Theramed Health Corporation Announces Closing of 2nd Tranche of Private Placement
-
Hemptown Announces Private Placement of Up to CDN$15 Million
-
Trulieve Cannabis Corp (TRUL:CN) (TCNNF) PT Raised to Cdn$27 at Canaccord Genuity
-
Stoke Therapeutics (STOK) IPO Opens 51% Higher
-
UPDATE: Zillow Group (ZG) (Z) PT Raised to $52 at Canaccord Genuity
-
Sesen Bio (SESN) Prices 20.41M Share & Warrants Offering at $1.47/Unit
-
Sesen Bio Announces Pricing of Public Offering of Common Stock and Warrants
-
MongoDB (MDB) PT Raised to $185 at Canaccord Genuity
-
Adobe (ADBE) PT Raised to $320 at Canaccord Genuity
-
Biohaven (BHVN) Prices 6.977M Shares Common Offering at $43/Sh
-
Stoke Therapeutics, Inc. (STOK) Prices 7.89M Share IPO at $18/Sh
-
POSaBIT Announces Brokered Private Placement
-
Canaccord Genuity Downgrades Royal Gold (RGLD) to Hold
-
Biohaven Announces Pricing Of $300 Million Public Offering Of Common Shares
-
Stoke Therapeutics Announces Pricing of Initial Public Offering
-
Sesen Bio (SESN) Plans Public Offering of Common Stock and Warrants
-
Sesen Bio Announces Proposed Public Offering of Common Stock and Warrants

